Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biolinerx Ltd ADR (NQ: BLRX )

1.760 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 2, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,301
Open 1.760
Bid (Size) 1.740 (20)
Ask (Size) 1.830 (4)
Prev. Close 1.760
Today's Range 1.760 - 1.760
52wk Range 0.5450 - 2.530
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BioLineRx Touts Encouraging Data From Therapy Trial For First Line Pancreatic Cancer
BioLineRx Ltd (NASDAQ: BLRX) announced data from the single-arm pilot phase of the investigator-initiated CheMo4METPANC Phase 2 combination trial of motixafortide and gemcitabine and nab-paclitaxel... 
Via Benzinga
HC Wainwright & Co. Maintains Buy Rating for BioLine Rx: Here's What You Need To Know
Via Benzinga

Performance

YTD
+170.77%
+170.77%
1 Month
-28.16%
-28.16%
3 Month
+8.64%
+8.64%
6 Month
+82.88%
+82.88%
1 Year
+86.09%
+86.09%

More News

Read More
Unity Software To Rally Around 60%? Here Are 10 Other Analyst Forecasts For Friday
Via Benzinga
BioLineRx Ltd. (NASDAQ: BLRX) Leading the Way in Tuesday Trading Based on Percentage Gain
Via Investor Brand Network
Earnings Scheduled For August 30, 2023
Via Benzinga
A Preview Of BioLine Rx's Earnings
Via Benzinga
A Preview Of BioLine Rx's Earnings
Via Benzinga
3 Cheap Biotech Stocks That Smart Investors Will Snap Up Now
Via InvestorPlace
3 Smart Penny Stocks with Huge Potential
Via InvestorPlace
The 3 Most Undervalued Biotech Stocks to Buy Now: June 2023
Via InvestorPlace
7 High-Potential Penny Stocks in the Biotech Sector
Via InvestorPlace
NASDAQ:BLRX Long Term Shareholder Alert: Investigation of Potential Wrongdoing at BioLineRx Ltd.
Via SBWire
The 3 Best Biotech Stocks Under $1 to Buy for April
Via InvestorPlace
Earnings Scheduled For May 24, 2023
Via Benzinga
BLRX FINAL DEADLINE TODAY: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages BioLineRx Ltd. Investors With Losses in Excess of $100K to Secure Counsel Before Important March 6 Deadline in Securities Class Action Filed by the Firm – BLRX
From The Rosen Law Firm, P.A.
Via Business Wire
BIOLINERX DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against BioLineRx Ltd. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against BioLineRx Ltd. (BLRX)
From Law Offices of Frank R. Cruz
Via Business Wire
BLRX DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages BioLineRx Ltd. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 6 Deadline in Securities Class Action Filed by the Firm - BLRX
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Avaya, BioLineRx, Enovix, and Southwest Airlines and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
BLRX DEADLINE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages BioLineRx Ltd. Investors to Secure Counsel Before Important March 6 Deadline in Securities Class Action Filed by the Firm - BLRX
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Avaya, BioLineRx, Enovix, and Southwest Airlines and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
BLRX FINAL DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages BioLineRx Ltd. Investors to Secure Counsel Before Important March 6 Deadline in Securities Class Action Filed by the Firm - BLRX
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
NASDAQ:BLRX Investor Notice: Deadline on March 6, 2023 in Lawsuit Against BioLineRx Ltd. Coming Up
Via SBWire
ROSEN, LEADING TRIAL ATTORNEYS, Encourages BioLineRx Ltd. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Filed by the Firm - BLRX
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Gaotu, Avaya, BioLineRx, and Enovix and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.